Zealand Pharma A/S (ZEAL): Price and Financial Metrics

Zealand Pharma A/S (ZEAL)

Today's Latest Price: $41.98 USD

2.27 (-5.13%)

Updated Feb 18 8:00pm

Add ZEAL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZEAL Stock Summary

  • Of note is the ratio of Zealand Pharma A's sales and general administrative expense to its total operating expenses; only 0.23% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Zealand Pharma A is higher than it is for about only 0.37% of US stocks.
  • With a year-over-year growth in debt of -100%, Zealand Pharma A's debt growth rate surpasses merely 0% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Zealand Pharma A, a group of peers worth examining would be TECK, IPWR, LOV, AKRX, and REGI.
  • ZEAL's SEC filings can be seen here. And to visit Zealand Pharma A's official web site, go to www.zealandpharma.com.
ZEAL Daily Price Range
ZEAL 52-Week Price Range

ZEAL Stock Price Chart More Charts

ZEAL Price/Volume Stats

Current price $41.98 52-week high $44.60
Prev. close $44.25 52-week low $14.40
Day low $41.49 Volume 25,400
Day high $42.06 Avg. volume 9,841
50-day MA $35.04 Dividend yield N/A
200-day MA $26.74 Market Cap 1.34B

Zealand Pharma A/S (ZEAL) Company Bio

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark.

ZEAL Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ZEAL Latest Social Stream

Loading social stream, please wait...

View Full ZEAL Social Stream

ZEAL Price Returns

1-mo N/A
3-mo 36.48%
6-mo 101.58%
1-year 179.68%
3-year N/A
5-year N/A
YTD 26.45%
2019 185.96%
2018 -14.63%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6316 seconds.